Virtu Financial’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-30,676
| Closed | -$1.59M | – | 1425 |
|
2019
Q2 | $1.59M | Buy |
+30,676
| New | +$1.59M | 0.09% | 164 |
|
2019
Q1 | – | Sell |
-36,142
| Closed | -$1.52M | – | 1406 |
|
2018
Q4 | $1.52M | Buy |
+36,142
| New | +$1.52M | 0.08% | 170 |
|
2018
Q3 | – | Sell |
-20,311
| Closed | -$1.16M | – | 1543 |
|
2018
Q2 | $1.16M | Buy |
20,311
+13,262
| +188% | +$759K | 0.07% | 322 |
|
2018
Q1 | $388K | Sell |
7,049
-44,550
| -86% | -$2.45M | 0.02% | 857 |
|
2017
Q4 | $2.89M | Buy |
+51,599
| New | +$2.89M | 0.15% | 110 |
|
2017
Q1 | – | Sell |
-5,341
| Closed | -$213K | – | 408 |
|
2016
Q4 | $213K | Buy |
+5,341
| New | +$213K | 0.02% | 404 |
|
2016
Q3 | – | Sell |
-57,736
| Closed | -$2.24M | – | 368 |
|
2016
Q2 | $2.24M | Sell |
57,736
-51,777
| -47% | -$2.01M | 0.3% | 64 |
|
2016
Q1 | $4.48M | Sell |
109,513
-5,764
| -5% | -$236K | 0.62% | 33 |
|
2015
Q4 | $8.24M | Buy |
115,277
+59,744
| +108% | +$4.27M | 1.17% | 12 |
|
2015
Q3 | $3.24M | Buy |
+55,533
| New | +$3.24M | 0.42% | 52 |
|